FHA
ENTA icon

First Horizon Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

First Horizon Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-373
Closed -$7K – 1450
2016
Q2 		$7K Hold
373
– – ﹤0.01% 1046
2016
Q1 		$9K Buy
373
+156
+72% +$4.34K ﹤0.01% 1012
2015
Q4 		$7K Sell
217
-348
-62% -$11.3K ﹤0.01% 985
2015
Q3 		$20K Buy
565
+36
+7% +$1.55K ﹤0.01% 797
2015
Q2 		$23K Buy
529
+21
+4% +$817 ﹤0.01% 798
2015
Q1 		$15K Buy
+508
New +$19.8K ﹤0.01% 921

Other funds holding ENTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Horizon Advisors's ENTA Position: Q3 2016 in Review

First Horizon Advisors sold out of Enanta Pharmaceuticals (ENTA) in Q3 2016, closing a stake of 373 shares — an estimated $7K sold.

First Horizon Advisors first reported a position in ENTA in Q1 2015 and held it in 6 quarters. The position peaked at $23K in Q2 2015. 136 funds tracked by Wall St. Rank hold ENTA as of Q3 2016.

  • First Horizon Advisors reported no remaining Enanta Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • First Horizon Advisors sold 373 Enanta Pharmaceuticals shares in Q3 2016, an estimated $7K.
  • First Horizon Advisors first reported a position in Enanta Pharmaceuticals in Q1 2015 and held it in 6 quarters.
  • First Horizon Advisors's Enanta Pharmaceuticals position peaked at $23K in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2016.

Based on First Horizon Advisors's 13F filing for Q3 2016, filed 28 Oct 2016.